BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

MERCURYLABORATORIES01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

MERCURYLABORATORIES01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-May-2023	D	Outcome of the Board Meeting - May 05, 2023 Mercury Laboratories Limited Board of Directors recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2022-23 subject to approval of shareholders at an ensuing Annual General Meeting. Fixes Book Closure for AGM and Payment of Dividend	20-Sep-2023
26-May-2022	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2022, inter alia, has recommended dividend @ 35% (Rs 3.50 per share) on the Equity Share Capital for the year 2021-22 subject to approval of shareholders at an ensuing Annual General Meeting.	19-Sep-2022
27-May-2021	D	Mercury Laboratories Limited -Outcome of Board Meeting held on May 27, 2021 The Meeting was commenced at 10:00 a.m. and concluded at 04:15 p.m..	20-Sep-2021
11-Feb-2021	D	Mercury Laboratories Limited -Outcome of Board Meeting held on February 11, 2021 . Meeting was commenced at 09:45 a.m.. and concluded at 01:00 p.m.	22-Feb-2021
30-May-2020	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2020, inter alia, has recommended dividend @ 20% (Rs. 2.00 per share) on the Equity Share Capital for the year 2019-20.	21-Sep-2020
29-May-2019	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 29, 2019, inter alia, has recommended dividend @ 15% (Rs. 1.50 per Share) on the Equity Share Capital for the year 2018-19.	19-Sep-2019
28-May-2018	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2018, inter alia, have recommended dividend @ 15% (Rs. 1.50 per Share) on the Equity Share Capital for the year 2017-18.	31-Aug-2018
19-May-2017	D	Mercury Laboratories Ltd has informed BSE that at the meeting of Board of Director held on May 19, 2017, has recommended dividend @ 15% (Rs. 1.50 per Share) on the Equity Share Capital for the year 2016-17.	15-Sep-2017
06-May-2016	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2016 has considered and approved the following: 1. Recommended payment of Dividend @ 15% (Rs. 1.5 per share ) on its Equity Share Capital, which would be paid, if approved by the shareholders, to the Shareholders holding shares as on the Record Date / Book Closure, which may be decided and notified. In future.	15-Sep-2016
01-Aug-2015	D	Mercury Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 31, 2015, inter alia, has recommended payment of Dividend @ 15% to the shareholders for the year 2014-15 which shall be paid, if approved, to the Shareholders holding shares of the Company as on September 25, 2015.	16-Sep-2015
05-Feb-2024	BC	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results of the	12-Feb-2024
30-Oct-2023	BC	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited Financial Results of the	08-Nov-2023
05-May-2023	BC	Outcome of the Board Meeting - May 05, 2023_Mercury Laboratories Limited Fixes Book Closure for AGM and Payment of Dividend Revised 42nd Annual Report along with AGM notice for the FY 2022-23	27-Sep-2023
05-May-2023	BC	Rs.3.5000 per share(35%)Final Dividend & A.G.M	21-Sep-2023
23-Jun-2023	BC	35% Dividend	20-Sep-2023

Announcement Date05-May-2023

Ex Dividend Date20-Sep-2023

Dividend(%)35

Announcement Date26-May-2022

Ex Dividend Date19-Sep-2022

Dividend(%)35

Announcement Date27-May-2021

Ex Dividend Date20-Sep-2021

Dividend(%)20

Announcement Date11-Feb-2021

Ex Dividend Date22-Feb-2021

Dividend(%)15

Announcement Date30-May-2020

Ex Dividend Date21-Sep-2020

Dividend(%)20

Announcement Date29-May-2019

Ex Dividend Date19-Sep-2019

Dividend(%)15

Announcement Date28-May-2018

Ex Dividend Date31-Aug-2018

Dividend(%)15

Announcement Date19-May-2017

Ex Dividend Date15-Sep-2017

Dividend(%)15

Announcement Date06-May-2016

Ex Dividend Date15-Sep-2016

Dividend(%)15

Announcement Date01-Aug-2015

Ex Dividend Date16-Sep-2015

Dividend(%)15

No Rights has been declared by MERCURYLABORATORIES

Book Closure

Record Date	Split Date	Purpose
12-Feb-2024	-	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve the Unaudited Financial Results of the
08-Nov-2023	-	Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited Financial Results of the
27-Sep-2023	-	Outcome of the Board Meeting - May 05, 2023_Mercury Laboratories Limited Fixes Book Closure for AGM and Payment of Dividend Revised 42nd Annual Report along with AGM notice for the FY 2022-23
21-Sep-2023	01 Jan'1900	Rs.3.5000 per share(35%)Final Dividend & A.G.M
20-Sep-2023	-	35% Dividend

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,679.65(+24.90/1.50%)	1,679.65	+24.90	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,336.30(-1.40/-0.10%)	1,336.30	-1.40	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,853.25(-36.65/-1.94%)	1,853.25	-36.65	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,538.75(-85.50/-0.99%)	8,538.75	-85.50	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹386.75(-8.80/-2.22%)	386.75	-8.80	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	17.11	22.76	18.32	19.43	16.23	22.07
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	17.11	22.76	18.32	19.43	16.23	22.07
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.18	0.36	0.15	0.48	0.58	0.22
Total Income	17.29	23.11	18.47	19.91	16.81	22.29
Total Expenditure	14.89	20.27	16.66	18.39	15.65	17.39
PBIDT	2.41	2.84	1.81	1.52	1.16	4.90
Interest	0.10	0.11	0.08	0.10	0.08	0.09
PBDT	2.31	2.73	1.73	1.42	1.08	4.81
Depreciation	0.72	0.71	0.68	0.62	0.63	0.62
Tax	0.47	0.64	0.35	0.44	0.00	1.13
Deferred Tax	-0.12	-0.12	-0.29	-0.01	-0.16	-0.08
Reported Profit After Tax	1.24	1.51	1.00	0.37	0.61	3.14
Extra-ordinary Items	0.00	0.00	0.00	0.02	0.00	0.00
Adjusted Profit After Extra-ordinary item	1.24	1.51	1.00	0.35	0.61	3.14

EPS (Unit Curr.)	10.30	12.56	8.33	3.05	5.05	26.19
EPS (Adj) (Unit Curr.)	10.30	12.56	8.33	3.05	5.05	26.19
Calculated EPS (Unit Curr.)	10.30	12.56	8.33	3.05	5.05	26.19
Calculated EPS (Adj) (Unit Curr.)	10.30	12.56	8.33	3.05	5.05	26.19
Calculated EPS (Ann.) (Unit Curr.)	41.22	50.26	33.33	12.22	20.22	104.75
Calculated EPS (Adj) (Ann.) (Unit Curr.)	41.22	50.26	33.33	12.22	20.22	104.75
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	1.20	1.20	1.20	1.20	1.20	1.20
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	14.09	12.48	9.88	7.82	7.15	22.20
PBDTM(%)	13.50	11.99	9.44	7.31	6.65	21.79
PATM(%)	7.25	6.63	5.46	1.90	3.76	14.23

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	1.20	1.20	1.20	1.20	1.20	1.20
Reserves Total	44.43	39.11	35.69	30.78	27.77	25.15
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	45.63	40.31	36.89	31.98	28.97	26.35
Secured Loans	2.94	2.72	4.58	3.43	5.61	6.81
Unsecured Loans	2.89	3.27	2.52	3.76	3.95	2.95
Total Debt	5.83	5.99	7.10	7.19	9.56	9.76
Total Liabilities	51.46	46.30	43.99	39.17	38.53	36.11
APPLICATION OF FUNDS :
Gross Block	43.96	43.04	41.18	36.58	35.44	30.21
Less : Accumulated Depreciation	19.70	17.22	14.82	12.92	11.06	9.43
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	24.26	25.82	26.36	23.66	24.38	20.78
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.13	0.00	0.00	0.00	0.00	0.24
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.01	0.01
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	6.90	6.78	5.16	5.51	6.78	7.69
Sundry Debtors	21.37	16.74	22.54	18.14	19.29	14.72
Cash and Bank	7.32	6.93	4.87	2.51	1.48	3.79
Loans and Advances	6.13	4.76	5.23	5.36	4.34	3.51
Total Current Assets	41.71	35.22	37.80	31.51	31.90	29.71
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	10.39	10.97	15.93	12.97	14.92	12.40
Provisions	2.67	1.70	2.04	1.23	0.94	0.58
Total Current Liabilities	13.06	12.67	17.97	14.20	15.86	12.98
Net Current Assets	28.66	22.55	19.82	17.31	16.03	16.73
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.40	0.31	0.28	0.00	0.00	0.00
Deferred Tax Liability	2.30	2.54	2.41	1.74	1.82	1.59
Net Deferred Tax	-1.90	-2.23	-2.13	-1.74	-1.82	-1.59
Total Assets	51.16	46.15	44.06	39.24	38.61	36.17
Contingent Liabilities	0.75	0.48	0.69	1.15	1.15	1.12

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	6.93	4.87	2.51	1.48	3.79
Net Cash from Operating Activities	2.45	5.19	8.21	5.49	5.22
Net Cash Used In Investing Activities	-1.06	-1.89	-4.62	-1.14	-4.99
Net Cash Used In Financing Activities	-1.01	-1.23	-1.24	-3.33	-2.54
Net Inc./Dec In Cash And Cash Equivalents	0.38	2.07	2.36	1.02	-2.31
Cash And Cash Equivalents At End Of The Year	7.32	6.93	4.87	2.51	1.48

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

73.66%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

26.34%

**Promoter pledged shareholding 73.66%

About Mercury Laboratories Ltd

Mercury Laboratories Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 105 crores. It has reported a sales of Rs. 17.11 crores and a net profit of Rs. 1.24 crores for the quarter ended December 2018. The company management includes Divyakant Ramniklal Zaveri, Rajendra R Shah,Dilip R Shah,Divyakant Ramniklal Zaveri,Bharat Dhirajlal Mehta,Paresh Mistry,Janki Shah (Mercury Laboratories Ltd) among others.

Chairman

Divyakant Ramniklal Zaveri

Registered office

1st Floor 18 Shreeji Bhuwan 51,Princess Street Mangaladas Rd,Mumbai,Maharashtra,400002

FAX :91-22-22015441

Background

Incorporation Year1982

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0